Morgan Stanley
OGI

Morgan Stanley’s Organigram Holdings OGI Stock Holding History

Morgan Stanley’s Portfolio OGI Stock Details OGI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$488K Sell
364,184
-268,053
-42% -$398K ﹤0.01% 5497
2025
Q4 		$1.06M Sell
632,237
-547,740
-46% -$942K ﹤0.01% 5158
2025
Q3 		$2.4M Buy
1,179,977
+993,610
+533% +$1.56M ﹤0.01% 4672
2025
Q2 		$252K Buy
186,367
+90,227
+94% +$110K ﹤0.01% 5760
2025
Q1 		$97.1K Buy
96,140
+45,195
+89% +$60.2K ﹤0.01% 6019
2024
Q4 		$82K Sell
50,945
-20,296
-28% -$33.1K ﹤0.01% 6132
2024
Q3 		$129K Buy
71,241
+46,567
+189% +$81.1K ﹤0.01% 5897
2024
Q2 		$38K Sell
24,674
-24,748
-50% -$44.9K ﹤0.01% 6256
2024
Q1 		$106K Sell
49,422
-32,192
-39% -$62.2K ﹤0.01% 5968
2023
Q4 		$107K Buy
81,614
+41,098
+101% +$50.5K ﹤0.01% 6137
2023
Q3 		$53.5K Sell
40,516
-29,877
-42% -$45K ﹤0.01% 6141
2023
Q2 		$110K Buy
70,393
+15,111
+27% +$29.1K ﹤0.01% 5905
2023
Q1 		$142K Buy
55,282
+12,537
+29% +$39.8K ﹤0.01% 5861
2022
Q4 		$137K Sell
42,745
-160,601
-79% -$604K ﹤0.01% 5831
2022
Q3 		$709K Buy
203,346
+142,409
+234% +$596K ﹤0.01% 5088
2022
Q2 		$223K Sell
60,937
-24,046
-28% -$123K ﹤0.01% 5842
2022
Q1 		$565K Sell
84,983
-262,830
-76% -$1.62M ﹤0.01% 5336
2021
Q4 		$2.44M Buy
347,813
+295,319
+563% +$2.51M ﹤0.01% 4417
2021
Q3 		$484K Sell
52,494
-157,990
-75% -$1.62M ﹤0.01% 5518
2021
Q2 		$2.41M Buy
210,484
+78,109
+59% +$889K ﹤0.01% 4490
2021
Q1 		$1.84M Buy
132,375
+105,448
+392% +$1.22M ﹤0.01% 4313
2020
Q4 		$143K Sell
26,927
-21,910
-45% -$112K ﹤0.01% 5760
2020
Q3 		$205K Sell
48,837
-12,835
-21% -$66.9K ﹤0.01% 5105
2020
Q2 		$385K Buy
61,672
+51,706
+519% +$348K ﹤0.01% 4733
2020
Q1 		$80K Sell
9,966
-62,872
-86% -$571K ﹤0.01% 5275
2019
Q4 		$714K Sell
72,838
-298
-0.4% -$3.52K ﹤0.01% 4730
2019
Q3 		$1.01M Buy
73,136
+35,424
+94% +$745K ﹤0.01% 4296
2019
Q2 		$971K Buy
+37,712
New +$1.05M ﹤0.01% 4240

Other funds holding OGI

TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.7B AUM 31.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley's OGI Position: Q1 2026 in Review

Morgan Stanley reduced its Organigram Holdings (OGI) stake by 42% in Q1 2026, selling an estimated $398K and leaving 364,184 shares worth $488K. The position accounts for ﹤0.01% of the portfolio, ranked #5497.

Morgan Stanley first reported a position in OGI in Q2 2019 and has held it in 28 quarters since. The position peaked at $2.44M in Q4 2021. 73 funds tracked by Wall St. Rank hold OGI as of Q1 2026.

  • Morgan Stanley held 364,184 shares of Organigram Holdings worth $488K as of Q1 2026.
  • Morgan Stanley sold 268,053 Organigram Holdings shares in Q1 2026, an estimated $398K.
  • Organigram Holdings made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5497 holding.
  • Morgan Stanley first reported a position in Organigram Holdings in Q2 2019 and has held it in 28 quarters since.
  • Morgan Stanley's Organigram Holdings position peaked at $2.44M in Q4 2021.
  • 73 funds tracked by Wall St. Rank held Organigram Holdings as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.